Scientific Articles about Ovarian Cancer

Return to index

This page contains a list of citations for selected publications authored by CDC's Division of Cancer Prevention and Control (DCPC) staff members. Fiscal years begin October 1 and end September 30; for example, fiscal year 2006 began October 1, 2005 and ended September 30, 2006.

Fiscal Year 2009

Coates RJ, Kolor K, Stewart SL, Richardson LC. Diagnostic markers for ovarian cancer screening: Not ready for routine clinical use. Clinical Cancer Research 2008;14(22):7575–7576.

Fiscal Year 2008

Hall IJ, Middlebrooks A, Coughlin SS. Population prevalence of first-degree family history of breast and ovarian cancer in the United States: implications for genetic testing.* The Open Health Services and Policy Journal 2008;1(1):34–37.

Rim SH, Berkowitz Z, Peipins L. Ovarian as a subsequent primary cancer among women cancer survivors, 1973–2004. Abstracts: 32nd Annual Meeting, American Society of Preventive Oncology, Bethesda, Maryland, March 16–18, 2008. Cancer Epidemiology, Biomarkers and Prevention 2008;17(2):460–465.

Fiscal Year 2007

Darcy KM, Tian C, Reed E. A Gynecologic Oncology Group study of platinum-DNA adducts and excision repair cross-complementation group 1 expression in optimal, stage III epithelial ovarian cancer treated with platinum-taxane chemotherapy. Cancer Research 2007;67(9):4474–4481.

Goff BA, Matthews BJ, Larson EH, Andrilla CH, Wynn M, Lishner DM, Baldwin LM. Predictors of comprehensive surgical treatment in patients with ovarian cancer. Cancer 2007;109(10):2031–2042.

Goff BA, Matthews BJ, Wynn M, Muntz HG, Lishner DM, Baldwin LM. Ovarian cancer: patterns of surgical care across the United States. Gynecologic Oncology 2006;103(2):383–390.

Herrinton LJ, Neslund-Dudas C, Rolnick SJ, Hornbrook MC, Bachman DJ, Darbinian JA, Jackson JM, Coughlin SS. Complications at the end of life in ovarian cancer. Journal of Pain and Symptom Management 2007;34(3):237–243.

Jackson JM, Rolnick SJ, Coughlin SS, Neslund-Dudas C, Hornbrook MC, Darbinian J, Bachman DJ, Herrinton LJ. Social support among women who died of ovarian cancer. Supportive Care in Cancer 2007;15(5):547–556.

Rolnick SJ, Jackson J, Nelson WW, Butani A, Herrinton LJ, Hornbrook M, Neslund-Dudas C, Bachman DJ, Coughlin SS. Pain management in the last six months of life among women who died of ovarian cancer. Journal of Pain and Symptom Management 2007;33(1):24–31.

Ryerson AB, Eheman C, Burton J, McCall N, Blackman D, Subramanian S, Richardson LC. Symptoms, diagnoses, and time to key diagnostic procedures among older U.S. women with ovarian cancer. Obstetrics and Gynecology 2007;109(5):1053–1061.

Wynn ML, Chang S, Peipins L. Temporal patterns of conditions and symptoms potentially associated with ovarian cancer. Journal of Women's Health 2007;16(7):971–986.

Fiscal Year 2006

Eheman CR, Peipins L, Wynn M, Ryerson B, Stewart SL, Coughlin SS, Hawkins NA, Saraiya M. Development of a public health research program for ovarian cancer. Journal of Women's Health 2006;15(4):339–345.

Seiden MV, Gordon AN, Bodurka DC, Matulonis UA, Penson RT, Reed E, Alberts DS, Weems G, Cullen M, McGuire WP 3rd. A phase II study of irofulven in women with recurrent and heavily pretreated ovarian cancer. Gynecologic Oncology 2006;101(1):55–61.

Fiscal Year 2004

Jacobellis J, Martin L, VanEenwyk J, Bradley LA, Kassim S, Jorgensen C, Litch JA, Myers MF. Genetic testing for breast and ovarian cancer susceptibility: Evaluating direct-to-consumer marketing—Atlanta, Denver, Raleigh-Durham, and Seattle, 2003. MMWR 2004;53(27):603–606.

Fiscal Year 2003

Goodman M, Howe HL, Tung KH, Hotes J, Miller B, Coughlin S, Chen VW. Incidence of ovarian cancer by race and ethnicity. North American Association of Central Cancer Registries. Cancer 2003;97(Suppl 10):2676–2685.

Hall HI, Tung KH, Hotes J, Logan P. Regional variations in ovarian cancer incidence in the United States, 1992–1997. Cancer 2003;97(Suppl 10):2701–2706.

Howe HL, Tung KH, Coughlin S, Jean-Baptiste R, Hotes J. Race/ethnic variations in ovarian cancer mortality. North American Association of Central Cancer Registries. Cancer 2003;97(Suppl 10):2686–2693.

Fiscal Year 2002

Coughlin SS, Hall IJ. Glutathione S-transferase polymorphisms and risk of ovarian cancer: A HuGE review. Genetics in Medicine 2002;4(4):250–257.

Fiscal Year 2000

Coughlin SS, Giustozzi A, Smith SJ, Lee NC. A meta-analysis of estrogen replacement therapy and risk of epithelial ovarian cancer. Journal of Clinical Epidemiology 2000;53(4):367–375.

*Links to non-Federal organizations found at this site are provided solely as a service to our users. These links do not constitute an endorsement of these organizations or their programs by CDC or the Federal Government, and none should be inferred. CDC is not responsible for the content of the individual organization Web pages found at these links.